|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.631
|
|
|
|
positive regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060213 |
4 |
0.412
|
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.398
|
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.348
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.300
|
|
|
|
mrna 3 end processing
|
GO:0031124 |
16 |
0.291
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.240
|
|
|
|
mrna catabolic process
|
GO:0006402 |
22 |
0.234
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.233
|
|
|
|
nuclear transcribed mrna catabolic process
|
GO:0000956 |
16 |
0.210
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.209
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.189
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.187
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.175
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.172
|
|
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
12 |
0.170
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.168
|
|
|
|
positive regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:1900153 |
5 |
0.155
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.140
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.139
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.137
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.135
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.133
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.131
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.130
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.128
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.126
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.121
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.115
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.111
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.109
|
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.104
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.099
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.098
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.097
|
|
|
|
regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060211 |
4 |
0.092
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.089
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.088
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.085
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.085
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.084
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.084
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.082
|
|
|
|
regulation of mrna catabolic process
|
GO:0061013 |
6 |
0.080
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.080
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.079
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.079
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.079
|
|
|
|
negative regulation of translation
|
GO:0017148 |
22 |
0.078
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.078
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.078
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.074
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.073
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.073
|
Human |
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.073
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.073
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.072
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.072
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.069
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.068
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.067
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.066
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.066
|
|
|
|
nuclear transcribed mrna poly a tail shortening
|
GO:0000289 |
7 |
0.066
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.065
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.064
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.063
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:0097296 |
2 |
0.063
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.062
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.061
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.061
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.060
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.060
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.058
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.058
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.058
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.057
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.055
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.055
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.054
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.052
|
|
|
|
positive regulation of toll like receptor 4 signaling pathway
|
GO:0034145 |
1 |
0.052
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.052
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.052
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.052
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.050
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.050
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.050
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.050
|
|
|
|
spongiotrophoblast layer development
|
GO:0060712 |
15 |
0.050
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.049
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.049
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.049
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.049
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.049
|
Rat |
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.048
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.048
|
Rat |
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.048
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.047
|
|
|
|
positive regulation of mrna metabolic process
|
GO:1903313 |
17 |
0.047
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.046
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.046
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.045
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.045
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.044
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.044
|
Human |
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.043
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.043
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.042
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.042
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.042
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.041
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.041
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.041
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.040
|
Human |
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.040
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.039
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.039
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.039
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.039
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.038
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.038
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.038
|
Human |
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.038
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.037
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.037
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.037
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.037
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.036
|
Rat |
|
|
urogenital system development
|
GO:0001655 |
261 |
0.036
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.036
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.036
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.036
|
|
|
|
positive regulation of mrna catabolic process
|
GO:0061014 |
5 |
0.035
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.035
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.035
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.035
|
|
|
|
positive regulation of protein ubiquitination
|
GO:0031398 |
27 |
0.034
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.034
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.033
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.033
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.033
|
|
|
|
negative regulation of b cell apoptotic process
|
GO:0002903 |
7 |
0.033
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.033
|
|
|
|
translation
|
GO:0006412 |
93 |
0.032
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.031
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.031
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.031
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.031
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.031
|
Human |
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.030
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.030
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.030
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
14 |
0.030
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.030
|
Rat |
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.030
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.030
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.029
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.029
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.029
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.029
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.029
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.029
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.028
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.028
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.028
|
Human |
|
|
immune effector process
|
GO:0002252 |
321 |
0.028
|
|
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.028
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.028
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.028
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.027
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.027
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.027
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.027
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.027
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.027
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.027
|
Human |
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.027
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.027
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.026
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.026
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.026
|
Human |
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.026
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.026
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.026
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.026
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.026
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.026
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.025
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.025
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.025
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.025
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.025
|
|
|
|
organelle fusion
|
GO:0048284 |
28 |
0.025
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.025
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.025
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.025
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.025
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.025
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.025
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
30 |
0.025
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.024
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.024
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.024
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.024
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.024
|
|
|
|
negative regulation of translation involved in gene silencing by mirna
|
GO:0035278 |
2 |
0.024
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.024
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.024
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.024
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.024
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.024
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.024
|
|
|
|
positive regulation of mrna processing
|
GO:0050685 |
16 |
0.024
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.024
|
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.024
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.023
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.023
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.023
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.023
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.023
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.023
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.023
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.023
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.023
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.022
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.022
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.022
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.022
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.022
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.022
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.022
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.021
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.021
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.021
|
|
|
|
cochlear nucleus development
|
GO:0021747 |
4 |
0.021
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.021
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.021
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.021
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.021
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.021
|
|
|
|
regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0000083 |
3 |
0.021
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.021
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.021
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.021
|
|
|
|
labyrinthine layer morphogenesis
|
GO:0060713 |
21 |
0.021
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.021
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.021
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.021
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.021
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.021
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.020
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.020
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.020
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.020
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.020
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.020
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.020
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.020
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.020
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.020
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.020
|
|
|
|
b cell apoptotic process
|
GO:0001783 |
19 |
0.020
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.020
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.020
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.020
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.020
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.020
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.020
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.019
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.019
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.019
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.019
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.019
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.019
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.019
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.019
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.019
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.019
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.019
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.019
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.019
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.019
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.019
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.019
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.019
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.019
|
|
|
|
regulation of b cell apoptotic process
|
GO:0002902 |
13 |
0.019
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.019
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.019
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.019
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.019
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.018
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.018
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.018
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.018
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.018
|
Human |
|
|
response to ischemia
|
GO:0002931 |
14 |
0.018
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.018
|
Human |
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.018
|
Human |
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.018
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.018
|
|
|
|
regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:1900151 |
5 |
0.018
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.018
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.018
|
|
|
|
chorio allantoic fusion
|
GO:0060710 |
8 |
0.018
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.018
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.018
|
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
0.018
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.018
|
Human |
|
|
organelle localization
|
GO:0051640 |
179 |
0.017
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.017
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.017
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.017
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.017
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.017
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.017
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.017
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.017
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.017
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.017
|
|
|
|
negative regulation of lymphocyte apoptotic process
|
GO:0070229 |
24 |
0.017
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.017
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.017
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.017
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.017
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.017
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.017
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.017
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.017
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.017
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.017
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.017
|
Mouse |
|
|
positive regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033145 |
4 |
0.017
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.016
|
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.016
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.016
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.016
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.016
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.016
|
|
|
|
t cell homeostatic proliferation
|
GO:0001777 |
4 |
0.016
|
|
|
|
regulation of mammary gland epithelial cell proliferation
|
GO:0033599 |
12 |
0.016
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.016
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.016
|
|
|
|
positive regulation of lymphocyte apoptotic process
|
GO:0070230 |
13 |
0.016
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.016
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.016
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.016
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.016
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.016
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.016
|
Human |
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.016
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.016
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.016
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.016
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.016
|
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.016
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.016
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.016
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.016
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.016
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.016
|
|
|
|
embryonic placenta morphogenesis
|
GO:0060669 |
25 |
0.016
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.016
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.015
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.015
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.015
|
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.015
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.015
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.015
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.015
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.015
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.015
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.015
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.015
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.015
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.015
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.015
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.015
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.015
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.015
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.015
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.015
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.015
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.015
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.015
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.015
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.015
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.015
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.015
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.015
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.015
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.015
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.015
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.015
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.015
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.014
|
|
|
|
negative regulation of calcium ion dependent exocytosis
|
GO:0045955 |
3 |
0.014
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.014
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.014
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.014
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.014
|
|
|
|
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
|
GO:0001844 |
4 |
0.014
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.014
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.014
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.014
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.014
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.014
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.014
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.014
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.014
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.014
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.014
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.014
|
Mouse |
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.014
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.014
|
Human |
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.014
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.014
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.014
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.014
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.014
|
Human |
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.014
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.014
|
Human |
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.014
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.014
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.014
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.014
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.014
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.014
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.014
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.014
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.014
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.014
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.014
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.014
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.014
|
|
|
|
mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900200 |
4 |
0.013
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.013
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.013
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.013
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.013
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.013
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.013
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.013
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.013
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.013
|
|
|
|
glycolipid metabolic process
|
GO:0006664 |
25 |
0.013
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.013
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.013
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.013
|
|
|
|
negative regulation of retinal cell programmed cell death
|
GO:0046671 |
2 |
0.013
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.013
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.013
|
|
|
|
negative regulation of protein kinase activity by regulation of protein phosphorylation
|
GO:0044387 |
2 |
0.013
|
|
|
|
apoptotic process involved in mammary gland involution
|
GO:0060057 |
4 |
0.013
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.013
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.013
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.013
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.013
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.013
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.013
|
|
|
|
positive regulation of intracellular estrogen receptor signaling pathway
|
GO:0033148 |
4 |
0.013
|
|
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.013
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.013
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.013
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.013
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.013
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.013
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.013
|
|
|
|
negative regulation of anoikis
|
GO:2000811 |
2 |
0.013
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.013
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.012
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.012
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.012
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.012
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001267 |
4 |
0.012
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.012
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.012
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.012
|
Rat |
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.012
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.012
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.012
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.012
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.012
|
|
|
|
protein insertion into mitochondrial membrane
|
GO:0051204 |
4 |
0.012
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.012
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.012
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.012
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.012
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.012
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.012
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.012
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.012
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.012
|
|
|
|
mammary gland involution
|
GO:0060056 |
9 |
0.012
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.012
|
|
